Bluejay Diagnostics (BJDX) Amortization of Deferred Charges (2022 - 2026)

Bluejay Diagnostics (BJDX) has 5 years of Amortization of Deferred Charges data on file, last reported at $21795.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortization of Deferred Charges fell 34.92% year-over-year to $21795.0; the trailing twelve-month figure through Mar 2026 stood at $84802.0 (down 30.69% YoY), and the FY2025 full-year result was $96499.0, down 21.85% from the prior year.
• Amortization of Deferred Charges grew to $21795.0 in Q1 2026, from $21394.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $44555.0 in Q3 2022 to a low of $17611.0 in Q3 2023.
• A 5-year average of $30811.2 and a median of $33981.0 in 2023 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges sank 60.47% in 2023 and surged 103.89% in 2024, its largest moves.
• Tracing BJDX's Amortization of Deferred Charges over 5 years: stood at $38243.0 in 2022, then declined by 11.14% to $33981.0 in 2023, then sank by 47.89% to $17707.0 in 2024, then increased by 20.82% to $21394.0 in 2025, then rose by 1.87% to $21795.0 in 2026.
• Business Quant data shows BJDX's Amortization of Deferred Charges at $21795.0 in Q1 2026, $21394.0 in Q4 2025, and $21000.0 in Q3 2025.